T cell-based therapies: Resources, products, and services for development and manufacturing
10 Sept 2023T cell-based therapies hold dramatic potential for treating intractable diseases by redirecting the power of living immune cells. The in vivo performance of cell therapies will improve with deeper understanding of cellular behavior, while technological advances contribute to process efficiency, scalability, and safety. In this eBook, explore several of the biological and manufacturing challenges for T cell therapies and discover how Bio-techne's solutions can help overcome these obstacles at each process stage.
Related Products
Request Quote for All Products
Ella Automated Immunoassay System
Bio-TechneElla is an automated ELISA platform that fits right on the benchtop of any laboratory. Ella simplifies multiplexing and presents consistent biomarker detection in less than 90 minutes, using only 25 µL of sample, and generating triplicate data, offering more flexibility than other instruments within the immunoassay space.